Advertisement
Organisation › Details
Protembis GmbH
Founded in 2013, Protembis is a medical device start-up company with its headquarters in the city of Aachen, Germany. The company’s vision is to bring the ProtEmbo® System into every interventional procedure which bears a risk of neurologic injury, thereby radically improving patient safety. *
Start | 2013-01-01 established | |
Industry | MedTech (medical technology) | |
Industry 2 | ProtEmbo® Cerebral Protection System | |
Person | Rasmus, Conrad (Protembis GmbH 2013– Managing Director + Co-Founder) | |
Person 2 | von Mangoldt, Karl (Protembis GmbH 2013– Managing Director + Co-Founder) | |
Region | Hamburg | |
Country | Germany | |
Street | 72 Neuer Wall | |
City | 20354 Hamburg | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-12-31 |
Advertisement
More documents for Protembis GmbH
- [1] Protembis GmbH. (7/30/24). "Press Release: German Medtech Protembis Gets €20 million EIB Backing for Technology to Protect Brain during Heart Treatment". Luxembourg & Aachen....
- [2] Protembis GmbH. (4/2/24). "Press Release: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial". New York, NY & Aachen....
- [3] Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top